Social networks
Your city
Thessaloniki ▼
Our phones
10 Tsimiski St., 54624, +30 2310 591491 , +30 (2310) 591 500
 Callback
x
+

Lysitsas Dimitrios

DIMITRIOS LYSITSAS, MD, PhD, MRCP

QUALIFICATIONS/EDUCATION

08.2010 Cardiology Specialist Training Certification
10.2010 PhD Thesis “Drug eluting stents and restenosis after PTCA”- Honours
03.2009 ALS provider
07.2006 MRCP PACES Examination-PASS
04.2005 MRCP Part 2 Written Examination- PASS
01.2004 MRCP Part 1 Written Examination-PASS
12.2000 PtychioIatrikes(MBBS equivalent), School of Medicine, University ofIoannina, Ioannina, Greece. Class of award: “Merit”
06.1993 High School Certificate, Veria, Greece, Grade: “Honours”

 

MEMBERSHIP OF PROFESSIONAL ORGANIZATIONS

Member of Royal College of Physicians of London
Member of European Heart Rhythm Association
Member of Sports Cardiology (European Association of Cardiovascular
Prevention and Rehabilitation

 

CARDIOLOGY TRAINING AND EMPLOYMENT

10.2013- on-going Consultant in Interventional Cardiology/Electrophysiology St Luke’s Hospital and Interbalcan Medical Centre, Thessaloniki, Greece
10.2010- 09.2013 Senior EP Fellow/SpR, Cardiology/Electrophysiology, Harefield Hospital,
09.2010- 10.2010 Clinical Fellow/SpR, Cardiology/Heart failure, Royal Brompton Hospital
01.2009-08.2010 Senior Specialist Registrar, Cardiology, University Hospital Ioannina
08.2008-11.2008 Specialist Registrar LAT, Cardiology, Addenbrookes Hospital, Cambridge University Hospital
08.2007-08.2008 Specialist Registrar LAT, Cardiology, Peterborough
District Hospital
01.2007- 08.2007 Registrar/Clinical Fellow, Cardiology, University Clinical Hospital of Walsgrave

 

PUBLICATIONS

Publications in peer-reviewed journals

1. Sioros L, Baltogiannis JG, Lysitsas DN, Kolettis TM Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: Lessons From One Case. Hospital Chronicles. 2014; 9: 27–32
2. Wang J, Malhotra A, Bajwa F, Lysitsas DN. Don't know much about embryology. CJEM 2014;16: 1-3
3. Lysitsas DN,Hussain W. Dabigatran: the end of warfarin. Cardiology International. 2011; 2: 5-6
4. Moulas A, Papakostas J, Eglezopoulos K, Papamichael N, Lysitsas D, Michalis L. Use of retinoic acid-eluting stents for preventing restenosis in an animal model. Cardiovascular Revascularisation Medicine. 2010;11:276-277
5. Kolettis TM, Lysitsas DN et al. Improved ‘cut-down’ technique for transvenous pacemaker lead implantation.Europace. 2010;12:1282-85
6. Lysitsas DN et al. Loop recorder implantation at the left axillary area. Europace. 2010;12:603
7. Lysitsas DN et al. Cardiac tamponade due to left atrium direct invasion by a large cell neuroendocrine metastatic carcinoma of the lung. Eur J Echocardiogr. 2008 May;9(3):428-9.
8. Lysitsas DN et al. Presentation of an embolisedAmplatzerseptaloccluder to the main pulmonary artery 2 years after implantation. Int J Cardiol. 2009 Jan 24;131(3):e106-7
9. Lysitsas DN et al."Antirestenotic effects of a novel polymercoated D-24851 eluting stent. Experimental data in a rabbit iliac artery model." CardiovascInterventRadiol. 2007 Nov-Dec;30(6):1192-200

Poster presentations in International meetings

1. Rochon M, Margerison N, Dimitrios Lysitsas, et al. Collaborative Working: Surveillance of Wound Infections in Implant Devices (pacemakers, loop systems and internal cardiac defibrillators). International Forum on Quality and Safety in Health Care 17-20 April, Paris
2. Jarman J, Lysitsas DNet al. Determinants of Recurrence Following Persistent Atrial Fibrillation Ablation.Cardiostim 2012
3. Jarman J, Lysitsas DN et alAdditional Linear Lesions Following Circumferential Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation Do Not Predict Procedural Success. Cardiostim 2012
4. Jarman J, Lysitsas DN et al. A Simple and Effective Score to Predict the Outcome of Persistent AF Ablation. HRS 2012
5. Jarman J, Lysitsas DN et al. Linear ablation at the left atrial roof and outcomes of paroxysmal atrial fibrillation. ECAS 2012
6. Lysitsas et al.Antirestenotic effects of a novel polymercoated D-24851 eluting stent. Experimental data in a rabbit iliac artery model."Hellenic Cardiology Congress 2004


Dr Dimitrios Lysitsas born in 13/10/75 in Veria, Greece, completed his Cardiology training in United Kingdom from 2004 to 2010 and subspecialized in Interventional Electropghysiology at Royal Brompton and Harefield Hospitals NHS Foundation Trust in London, UK.

Royal Brompton and Harefield NHS Foundation Trust is recognized by the Royal College of Physicians in the United Kingdom for training purposes, in accordance with the directive 2005/36/EC of the European Union. It is one of the highest volume electrophysiology centers in United Kingdom performing >1200 ablations and >600 pacing device implantation per year.

He is currently acting as Consultant Inteventional Electrophysiologist in Interbalcan Medical Centre in a -state of the art- electrophysiology Lab (CARTO 3-3D mapping system, SmartTouch ablation catheter etc), performing diagnostic electrophysiology studies, ablation of conventional and complex arrhythmias (supraventricular tachycardia, atrial flutter and fibrillation, ventricular tachycardia), implantation of pacemakers and complex devices (biventricular pacemakers and defibrillators), implantation of left atrial appendage occlusion devices etc.